References

  1. Badie F, Arshadi M, Mohsenpoor M, Gharibvand SS. Drug Resistance Pattern of Mycobacterium tuberculosis Isolates From Patients Referred to TB Reference Laboratory in Ahvaz. Osong Public Health and Research Perspectives. 2016;7(1):32-35. PubMed | Google Scholar

  2. Ao W, Aldous S, Woodruff E, Hicke B, Rea L, Kreiswirth B, Jenison R. Rapid detection of rpoB gene mutations conferring rifampin resistance in Mycobacterium tuberculosis. Journal of Clinical Microbiology. 2012; 50(7):2433-2440. PubMed | Google Scholar

  3. GangulyJ, Ray S, Nandi S, Halder S, Kundu S, Mandal A. A Study To Evaluate Pattern of Rifampicin Resistance in Cases of Sputum Positive Pulmonary Tuberculosis. Journal of Evolution of Medical and Dental Sciences. 2015; 4(28): 4762-4768. PubMed | Google Scholar

  4. Hauck Y, Fabre M, Verguand G, Soler C, Pourcel C. Comparison of two commercial assays for characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin. J Antimicrobiol Chemother. 2009; 64(2):1-4. PubMed | Google Scholar

  5. Farooqi J Q, Khan E, Alam S M Z, Ali A, Hasan Z, Hasan R. Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan. The Journal of the Pakistan Medical Association. 2012; 62(8): 767-772. PubMed | Google Scholar

  6. Johnson R, Streicher E M, Louw G E, Warren R M, van Helden P D, Victor T C. Drug resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol. 2006; 8(2): 97-112. PubMed | Google Scholar

  7. Somoskovi A, Parsons L M, Salfinger M. The molecular basis of resistance to isoniazid, rifampicin and pyrazinamide in Mycobacterium tuberculosis. Respir Res. 2001; 2(3): 164-168. PubMed | Google Scholar

  8. Abdella K, Abdissa K, Kebede W, Abebe G. Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health. 2015; 15: 599. PubMed | Google Scholar

  9. Miotto P, Cirillo D M, Migliori G B. Drug resistance in Mycobacterium tuberculosis: molecular mechanisms challenging fluoroquinolones and pyrazinamide effectiveness. Chest. 2015; 147(4): 1135-1143. PubMed | Google Scholar

  10. WHO.Global Tuberculosis Report 2014. Zhurnal Eksperimental?noi I Teoreticheskoi Fiziki. 2014; 1-134. PubMed | Google Scholar

  11. WHO Global tuberculosis. Global tuberculosis report 2016 Accessed 27/06/2017.

  12. World Health Organization. 2010. Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010 Global report surveillance and response. Google Scholar

  13. World Health Organization. (2014). Xpert MTB / RIF implementation.WHO Manual Accessed 27/06/2017
  14. World Health Organization.Multidrug and extensively drug resistant tuberculosis Accessed 27/06/2017
  15. Ascp K J M. GeneXpert MTB / RIF Performance Characteristics in a State Public Health Laboratory Context.Pan Afr Med J. 2016; 25: 129. PubMed | Google Scholar

  16. Ocheretina O, Escuyer,V E, Mabou M M, Royal-Mardi G, Collins S, Vilbrun S C, Fitzgerald D W. Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results. PLoS ONE. 2014; 9(3):e90569. PubMed | Google Scholar

  17. Telenti A P, Imboden P, Marchesi F, Lowrie D, Cole M, Colston M J, Matter L, Schopfer K, Bodmer T. Detection of rifampicin resistance mutations in Mycobacterium tuberculosis. Lancet. 1993; 341(8846): 647-650. PubMed | Google Scholar

  18. Rufai S B, Kumar P, Singh A, Prajapati S, Balooni V, Singh S. Comparison of xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.Journal of Clinical Microbiology. 2014; 52(6): 1846-1852. PubMed | Google Scholar

  19. Hoshide M, Quan L, Rodrigues C, Warren R, Victor T, EvascoH B, Tupasi T, Crudu V, DouglasJ T. Geographical Differences Associated with SNPs in Nine Gene Targets among Resistant Clinical Isolates of Mycobacterium tuberculosis. J Clin Microbiol. 2013 Nov;51(11):3913. PubMed | Google Scholar

  20. Racheal S D M, Zephaniah D, Reggie M, Kerina D, Babill S P, Peter M. Diagnosis of multi-drug resistant tuberculosis mutations using Hain line probe assay and GeneXpert: a study done in Zimbabwe. British Journal of Medicine and Medical Research. 2015; 5(8):1044-1052. PubMed | Google Scholar

  21. Metcalfe J Z, Makumbirofa S, MakamureB, Sandy C, Bara W, Mungofa S, Hopewell PC, Mason P. Drug-resistant tuberculosis in High risk groups Zimbabwe. Emerging infectious diseases. 2014; 20(1): 135-138. PubMed | Google Scholar

  22. Torres J N, Paul L V, Rodwell T C, Victor T C, Amallraja A M, Elghraoui A,Valafar F. Novel katG mutations causing isoniazid resistance in clinical M: tuberculosis isolates. Emerging Microbes & Infections. 2015; 4(April): e42. PubMed | Google Scholar

  23. Rahman A, Sahrin M, Afrin S, Earley K, Ahmed S. Comparison of Xpert MTB / RIF Assay and GenoType MTBDR plus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance. Mycobacterium tuberculosis. 2016; 11(4): 1-11. PubMed | Google Scholar

  24. Biadglegne F, Tessema B, Rodloff A C, Sack U. Magnitude of gene mutations conferring drug resistance in Mycobacterium tuberculosis isolates from lymph node aspirates in ethiopia. International Journal of Medical Sciences. 2013; 10(11): 1589-1594. PubMed | Google Scholar

  25. Mohajeri P, Sadri H, Farahani A, Norozi B, Atashi S. Frequency of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis Strains Isolated from Patients in West of Iran. Microbial Drug Resistance (Larchmont, NY). 2015; 21(3): 315-319. PubMed | Google Scholar

  26. Osman M, Simpson J A, Caldwell J, Bosman M, Nicol M P. GeneXpert MTB/RIF version g4 for identification of rifampin-resistant tuberculosis in a programmatic setting. Journal of Clinical Microbiology. 2014; 52(2): 635-637. PubMed | Google Scholar

  27. Ahmad S, Al-Mutairi N M, Mokaddas E. Variations in the occurrence of specific rpoB mutations in rifampicin resistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in Kuwait. Indian Journal of Medical Research. 2012; 135(5):756-762. PubMed | Google Scholar

  28. Doustdar F, Khosravi A D, Farnia P, Bahrmand A R, Masjedi M R, Velayati A A. Mutations in rpoB gene and genotypes of rifampin resistant Mycobacterium tuberculosis isolates in Iran. Tanaffos. 2008; 7(2): 11-17. PubMed | Google Scholar

  29. Tadesse M, Aragaw D, Dimah B, Efa F, Abdella K, Kebede W, Abebe G. Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia. International Journal of Mycobacteriology. 2016; 5(2): 185-191. PubMed | Google Scholar

  30. Ganguly J, Ray S, Nandi S, Halder S, KunduS, Mandal A. A Study To Evaluate Pattern of Rifampicin Resistance in Cases of Sputum Positive Pulmonary Tuberculosis. Journal of Evolution of Medical and Dental Sciences. 2015; 4(28): 4762-4768. PubMed | Google Scholar

  31. Minh N N, Van Bac N, Son N T, Lien V T K, Ha C H, Cuong N H, Le T H. Molecular characteristics of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Vietnam. Journal of Clinical Microbiology. 2012; 50(3):598-601. PubMed | Google Scholar

  32. Pang Y, Lu J, Wang Y, Song Y, Wang S, Zhao Y. Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 2013; 57(2): 893-900. PubMed | Google Scholar

  33. Van Deun A, Aung KJ M, Hossain M A, De Rijk P, Gumusboga M, Rigouts L, De Jong B C. Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients. International Journal of Tuberculosis and Lung Disease. 2015; 19(2):185-190. PubMed | Google Scholar

  34. Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, Wright A. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. Journal of Clinical Microbiology. 2009; 47(11):3501-3506. PubMed | Google Scholar

  35. Mani C, Selvakumar N, Narayanan S, Narayanan PR. Mutations in the rpoB gene of multidrug- resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol. 2001; 39(8):2987-2990. PubMed | Google Scholar

  36. Wang S, Zhao B, Song Y, Zhou Y, Pang Y, Ou X, Li Q. Molecular characterization of the rpoB gene mutations of Mycobacterium tuberculosis isolated from China. J Clin Microbiol. 2013; 1(1): 1-8. PubMed | Google Scholar

  37. Kumar P, Kumar P, Balooni V, Singh S. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India. International Journal of Tuberculosis and Lung Disease. 2015; 19(4): 434-439. PubMed | Google Scholar

  38. Metchock B, Abmm D. New TB Diagnostic Tools and the Challenges of Interpreting Discordant Results. Lung India. July2012; 43 (9): 1-43. PubMed | Google Scholar

  39. N'guessan Kouassi K, Riccardo A, Dutoziet ChristianC, André G, Férilaha C, Hortense SA,Mireille D. Genotyping of mutations detected with GeneXpert. International Journal of Mycobacteriology. 2016; 5(2):142-147. PubMed | Google Scholar

  40. Pang Y, Lu J, Wang Y, Song Y, Wang S, Zhao Y. Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 2013; 57(2): 893-900. PubMed | Google Scholar

  41. Rigouts L, Gumusboga M, De Rijk W B, Nduwamahoro E, Uwizeye C, De Jong B, Van Deun A. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations. Journal of Clinical Microbiology. 2013; 51(8):2641-2645. PubMed | Google Scholar

  42. Blakemore R. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol. 2010; 48(7): 2495-2501. PubMed | Google Scholar

  43. Zhang M, Yue J, Yang Y, Zhang H M, Lei J Q, Jin R L, Zhang X L, Wang H H. Detection of mutation associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J Clin Microbiol. 2005; 43(11):5477-5482. PubMed | Google Scholar

  44. Green E, Obi C L, De Villiers B E, Sein P P, Letsoalo T, Hoosen AA, Bessong PO. Molecular characterization of resistant Mycobacterium tuberculosis from Dr George Mukhari hospital, Pretoria, South Africa. South Afr, J Epidemiol Infect. 2008; 23(3):11-14. PubMed | Google Scholar

  45. Boakye-Appiah J K, Steinmetz A R, Pupulampu P, Ofori-Yirenkyi S, Tetteh I, Frimpong M, Phillips RO. High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana. International Journal of Mycobacteriology. 2016; 5(2): 226-230. PubMed | Google Scholar

  46. Doustdar F, Khosravi A D, Farnia P, Bahrmand A R, Masjedi M R, Velayati A A. Mutations in rpoB gene and genotypes of rifampin resistant Mycobacterium tuberculosis isolates in Iran. Tanaffos. 2008; 7(2): 11-17. PubMed | Google Scholar

  47. Jain A, Mondal R. Extensively drug resistant tuberculosis: current challenges and threats. FEMS Immunol Med Microbiol. 2008; (53):145-150. PubMed | Google Scholar

  48. Khan M M, Alves M S, Ali S, Sherwani S K, Baig M A, Siddiqui A A, Kamal M. Depiction of new mutations in the rpoB gene associated with rifampin resistance in clinical isolates of Mycobacterium tuberculosis. BMC Infect Dis. 2013; 4(11): 1723-1727. PubMed | Google Scholar